Your browser doesn't support javascript.
loading
A New CYP2E1 Inhibitor, 12-Imidazolyl-1-dodecanol, Represents a Potential Treatment for Hepatocellular Carcinoma.
Diesinger, Torsten; Lautwein, Alfred; Bergler, Sebastian; Buckert, Dominik; Renz, Christian; Dvorsky, Radovan; Buko, Vyacheslav; Kirko, Siarhei; Schneider, Edith; Kuchenbauer, Florian; Kumar, Mukesh; Günes, Cagatay; Genze, Felicitas; Büchele, Berthold; Simmet, Thomas; Haslbeck, Martin; Masur, Kai; Barth, Thomas; Müller-Enoch, Dieter; Wirth, Thomas; Haehner, Thomas.
Afiliación
  • Diesinger T; Chair of Biochemistry and Molecular Medicine, Witten/Herdecke University, Faculty of Health/School of Medicine, Alfred-Herrhausen-Straße 50, 58448 Witten, Germany.
  • Lautwein A; Institute of Physiological Chemistry, University of Ulm, Albert-Einstein-Allee 11, 89081 Ulm, Germany.
  • Bergler S; Department of Internal Medicine, Neu-Ulm Hospital, Krankenhausstraße 11, 89231 Neu-Ulm, Germany.
  • Buckert D; Institute of Physiological Chemistry, University of Ulm, Albert-Einstein-Allee 11, 89081 Ulm, Germany.
  • Renz C; Institute of Physiological Chemistry, University of Ulm, Albert-Einstein-Allee 11, 89081 Ulm, Germany.
  • Dvorsky R; Institute of Physiological Chemistry, University of Ulm, Albert-Einstein-Allee 11, 89081 Ulm, Germany.
  • Buko V; Department of Internal Medicine II, University Hospital Ulm, Albert-Einstein-Allee 23, 89081 Ulm, Germany.
  • Kirko S; Institute of Physiological Chemistry, University of Ulm, Albert-Einstein-Allee 11, 89081 Ulm, Germany.
  • Schneider E; Institute of Biochemistry and Molecular Biology II, Medical Faculty of the Heinrich Heine University Düsseldorf, Moorenstraße 5, 40225 Düsseldorf, Germany.
  • Kuchenbauer F; Max Planck Institute of Molecular Physiology, Otto-Hahn-Straße 11, 44227 Dortmund, Germany.
  • Kumar M; Division of Biochemical Pharmacology, Institute of Biochemistry of Biologically Active Compounds, National Academy of Sciences, Bulvar Leninskogo Komsomola, Dom 50, Grodno 230030, Belarus.
  • Günes C; Department of Biotechnology, University of Medical Sciences, Ulica Jana Kilinskiego 1, 15-089 Bialystok, Poland.
  • Genze F; Division of Biochemical Pharmacology, Institute of Biochemistry of Biologically Active Compounds, National Academy of Sciences, Bulvar Leninskogo Komsomola, Dom 50, Grodno 230030, Belarus.
  • Büchele B; Department of Internal Medicine III, University Hospital Ulm, Albert-Einstein-Allee 23, 89081 Ulm, Germany.
  • Simmet T; University of British Columbia, Terry Fox Laboratory, 675 West 10th Avenue, Vancouver, BC V5Z 1L3, Canada.
  • Haslbeck M; Department of Urology, University Hospital Ulm, Albert-Einstein-Allee 23, 89081 Ulm, Germany.
  • Masur K; Department of Urology, University Hospital Ulm, Albert-Einstein-Allee 23, 89081 Ulm, Germany.
  • Barth T; Institute of Pharmacology of Natural Products and Clinical Pharmacology, University Ulm, Helmholtzstraße 20, 89081 Ulm, Germany.
  • Müller-Enoch D; Institute of Pharmacology of Natural Products and Clinical Pharmacology, University Ulm, Helmholtzstraße 20, 89081 Ulm, Germany.
  • Wirth T; Institute of Pharmacology of Natural Products and Clinical Pharmacology, University Ulm, Helmholtzstraße 20, 89081 Ulm, Germany.
  • Haehner T; Chair of Biotechnology, TUM Department of Chemistry, Technical University of Munich, Lichtenbergstraße 4, 85748 Garching, Munich, Germany.
Can J Gastroenterol Hepatol ; 2021: 8854432, 2021.
Article en En | MEDLINE | ID: mdl-33604316

Texto completo: 1 Colección: 01-internacional Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Can J Gastroenterol Hepatol Año: 2021 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Can J Gastroenterol Hepatol Año: 2021 Tipo del documento: Article País de afiliación: Alemania